Workflow
Precision genetic medicine
icon
搜索文档
Solid Biosciences Inc. (SLDB) Presents At Citi's Biopharma Back To School Conference Transcript
Seeking Alpha· 2025-09-03 04:28
Question-and-Answer SessionSo let's just start with just an overview question, if we could, just introduce the company, the focus of the company, what are some of the key programs, and then we can get into detail on each of them.Alexander CumboPresident, CEO & Director Yes. Thank you, [indiscernible] for the invitation. Solid Biosciences is a precision genetic medicine company. We primarily focus right now on gene therapy. Three main drugs that are going to be either -- that are in the clinic, IND is open a ...
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24
Globenewswire· 2025-07-22 20:00
SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. ("Calidi" or the "Company") (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, is pleased to invite investors to a webinar on July 24, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Calidi's CEO, Eric Poma, Ph.D. Attendees will gain insights into Calidi's pioneer ...
Solid Biosciences to Participate at the Jefferies Global Healthcare Conference
Globenewswire· 2025-05-28 20:00
文章核心观点 - 生命科学公司Solid Biosciences宣布总裁兼首席执行官Bo Cumbo和首席医疗官Gabriel Brooks将参加杰富瑞全球医疗保健会议的炉边谈话 [1] 公司活动 - 总裁兼首席执行官Bo Cumbo和首席医疗官Gabriel Brooks将于6月4日下午2点参加杰富瑞全球医疗保健会议的炉边谈话 [1] - 炉边谈话将进行网络直播,可在公司网站投资者板块的活动页面观看,重播将在该页面存档30天 [2] - 机构投资者若想在会议期间与管理层会面,可联系其杰富瑞代表 [2] 公司介绍 - 公司专注于推进针对罕见神经肌肉和心脏疾病的基因疗法候选产品组合,包括杜氏肌营养不良症、弗里德赖希共济失调等 [3] - 公司还致力于开发基因调节剂创新库和其他赋能技术,有望对跨行业的基因疗法递送产生重大影响 [3] - 公司由受杜氏肌营养不良症直接影响的人创立,以患者为中心,使命是改善患有严重罕见疾病患者的日常生活 [3] 公司联系方式 - 投资者联系人为投资者关系和企业传播总监Nicole Anderson,邮箱为investors@solidbio.com [4] - 媒体联系人为FINN Partners的Glenn Silver,邮箱为glenn.silver@finnpartners.com [4]
Solid Biosciences to Participate at The Citizens Life Sciences Conference
Globenewswire· 2025-04-30 20:00
文章核心观点 - 生命科学公司Solid Biosciences宣布总裁兼首席执行官将参加5月7日下午12:30的炉边谈话 [1] 公司活动 - 总裁兼首席执行官Bo Cumbo将参加5月7日下午12:30在The Citizens Life Sciences Conference的炉边谈话 [1] - 炉边谈话将进行网络直播,可在公司网站投资者板块活动页面观看,重播将存档30天 [2] - 机构投资者若想在会议期间与管理层会面,可联系其Citizens代表 [2] 公司介绍 - 公司专注推进针对罕见神经肌肉和心脏疾病的基因疗法候选产品组合,还致力于开发基因调节剂创新库和其他赋能技术 [3] - 公司由受杜氏肌营养不良症影响者创立,使命是改善患有罕见疾病患者的日常生活 [3] 联系方式 - 投资者联系人为Nicole Anderson,邮箱为investors@solidbio.com [4] - 媒体联系人为Glenn Silver,邮箱为glenn.silver@finnpartners.com [4]